Literature DB >> 24554666

Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Christine Johnston1, Jia Zhu, Lichen Jing, Kerry J Laing, Christopher M McClurkan, Alexis Klock, Kurt Diem, Lei Jin, Jeffrey Stanaway, Elizabeth Tronstein, William W Kwok, Meei-Li Huang, Stacy Selke, Youyi Fong, Amalia Magaret, David M Koelle, Anna Wald, Lawrence Corey.   

Abstract

UNLABELLED: Genital herpes simplex virus (HSV) reactivation is thought to be anatomically and temporally localized, coincident with limited ganglionic infection. Short, subclinical shedding episodes are the most common form of HSV-2 reactivation, with host clearance mechanisms leading to rapid containment. The anatomic distribution of shedding episodes has not been characterized. To precisely define patterns of anatomic reactivation, we divided the genital tract into a 22-region grid and obtained daily swabs for 20 days from each region in 28 immunocompetent, HSV-2-seropositive persons. HSV was detected via PCR, and sites of asymptomatic HSV shedding were subjected to a biopsy procedure within 24 h. CD4(+) and CD8(+) T cells were quantified by immunofluorescence, and HSV-specific CD4(+) T cells were identified by intracellular cytokine cytometry. HSV was detected in 868 (7%) of 11,603 genital swabs at a median of 12 sites per person (range, 0 to 22). Bilateral HSV detection occurred on 83 (67%) days with shedding, and the median quantity of virus detected/day was associated with the number of sites positive (P < 0.001). In biopsy specimens of asymptomatic shedding sites, we found increased numbers of CD8(+) T cells compared to control tissue (27 versus 13 cells/mm(2), P = 0.03) and identified HSV-specific CD4(+) T cells. HSV reactivations emanate from widely separated anatomic regions of the genital tract and are associated with a localized cellular infiltrate that was demonstrated to be HSV specific in 3 cases. These data provide evidence that asymptomatic HSV-2 shedding contributes to chronic inflammation throughout the genital tract. IMPORTANCE: This detailed report of the anatomic patterns of genital HSV-2 shedding demonstrates that HSV-2 reactivation can be detected at multiple bilateral sites in the genital tract, suggesting that HSV establishes latency throughout the sacral ganglia. In addition, genital biopsy specimens from sites of asymptomatic HSV shedding have increased numbers of CD8(+) T cells compared to control tissue, and HSV-specific CD4(+) T cells are found at sites of asymptomatic shedding. These findings suggest that widespread asymptomatic genital HSV-2 shedding is associated with a targeted host immune response and contributes to chronic inflammation throughout the genital tract.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24554666      PMCID: PMC3993786          DOI: 10.1128/JVI.03285-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR.

Authors:  Keith R Jerome; Meei-Li Huang; Anna Wald; Stacy Selke; Lawrence Corey
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  Distribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridization.

Authors:  Y Obara; Y Furuta; T Takasu; S Suzuki; H Suzuki; S Matsukawa; Y Fujioka; H Takahashi; T Kurata; K Nagashima
Journal:  J Med Virol       Date:  1997-06       Impact factor: 2.327

3.  Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

Authors:  A Wald; L Corey; R Cone; A Hobson; G Davis; J Zeh
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

4.  Zosteriform spread of herpes simplex virus type 2 genital infection in the guinea-pig.

Authors:  D I Bernstein; L R Stanberry
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

5.  Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Authors:  A Wald; J Zeh; S Selke; T Warren; A J Ryncarz; R Ashley; J N Krieger; L Corey
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

6.  Virologic characteristics of subclinical and symptomatic genital herpes infections.

Authors:  A Wald; J Zeh; S Selke; R L Ashley; L Corey
Journal:  N Engl J Med       Date:  1995-09-21       Impact factor: 91.245

7.  Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture.

Authors:  K D Croen; J M Ostrove; L Dragovic; S E Straus
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

8.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

Review 9.  Genital herpes simplex virus infections: clinical manifestations, course, and complications.

Authors:  L Corey; H G Adams; Z A Brown; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

10.  Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.

Authors:  Monique van Velzen; Lichen Jing; Albert D M E Osterhaus; Alessandro Sette; David M Koelle; Georges M G M Verjans
Journal:  PLoS Pathog       Date:  2013-08-15       Impact factor: 6.823

View more
  37 in total

Review 1.  Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Authors:  Joshua T Schiffer; Sami L Gottlieb
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

2.  Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition.

Authors:  Meena Ramchandani; Stacy Selke; Amalia Magaret; Gail Barnum; Meei-Li Wu Huang; Lawrence Corey; Anna Wald
Journal:  Sex Transm Infect       Date:  2017-11-25       Impact factor: 3.519

3.  Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.

Authors:  Warren Phipps; Edith Nakku-Joloba; Elizabeth M Krantz; Stacy Selke; Meei-Li Huang; Fred Kambugu; Jackson Orem; Corey Casper; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2015-10-20       Impact factor: 5.226

4.  Herpes Simplex Virus 2 in Autonomic Ganglia: Evidence for Spontaneous Reactivation.

Authors:  Julianna R Pieknik; Andrea S Bertke; Philip R Krause
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 5.  Herpes Simplex Virus Latency Is Noisier the Closer We Look.

Authors:  Navneet Singh; David C Tscharke
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

6.  Increased Frequency of Virus Shedding by Herpes Simplex Virus 2-Infected Guinea Pigs in the Absence of CD4+ T Lymphocytes.

Authors:  Nigel Bourne; Clarice L Perry; Brianne N Banasik; Aaron L Miller; Mellodee White; Richard B Pyles; Hubert Schäfer; Gregg N Milligan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 7.  The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.

Authors:  Tiffany Kuo; Christine Wang; Tina Badakhshan; Sravya Chilukuri; Lbachir BenMohamed
Journal:  Vaccine       Date:  2014-10-16       Impact factor: 3.641

8.  Tissue-resident T cell-derived cytokines eliminate herpes simplex virus-2-infected cells.

Authors:  Pavitra Roychoudhury; David A Swan; Elizabeth Duke; Lawrence Corey; Jia Zhu; Veronica Davé; Laura Richert Spuhler; Jennifer M Lund; Martin Prlic; Joshua T Schiffer
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

9.  Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons.

Authors:  Emily S Ford; Amalia S Magaret; Cedric W Spak; Stacy Selke; Steve Kuntz; Lawrence Corey; Anna Wald
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

10.  Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.

Authors:  Tajanna Stinn; Steve Kuntz; Dana Varon; Meei-Li Huang; Stacy Selke; Samuel Njikan; Emily S Ford; Joan Dragavon; Robert W Coombs; Christine Johnston; Marta E Bull
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.